Animal Vaccine Market to Reach $23,604.7 million in 2035, Growing at 6.8% CAGR

Animal vaccine market valued at $12,306.8 million in 2025 and is projected to reach $23,604.7 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026-2035). The market encompasses preventive biological products developed for livestock and companion animals to protect against infectious diseases, enhance productivity, and ensure food safety. The market is witnessing robust global growth supported by rising livestock production, increasing demand for animal protein, expanding pet ownership, and stricter biosecurity regulations. Growth is further reinforced by government-supported vaccination campaigns, zoonotic disease surveillance initiatives, and growing investments by animal health pharmaceutical companies in next-generation recombinant and vector-based vaccines. Rising prevalence of transboundary animal diseases such as foot-and-mouth disease, avian influenza, African swine fever, and aquaculture infections is accelerating vaccination coverage globally. Technological advancements in recombinant DNA platforms, multivalent vaccines, and thermostable formulations are further strengthening long-term market outlook.

Browse the full report description of “Animal Vaccine Market Size, Share & Trends Analysis Report by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/animal-vaccine-market

According to the World Organization for Animal Health and the Food and Agriculture Organization, global livestock populations exceed 33 billion chickens, 1.5 billion cattle, 1.3 billion sheep, and nearly 1 billion pigs, forming the primary addressable base for veterinary vaccination programs worldwide. In addition, the World Health Organization highlights that over 60% of emerging infectious diseases are zoonotic in origin, reinforcing the strategic importance of preventive animal immunization in global health security.

Key Statistics: Animal Vaccines at a Glance

• Global poultry population exceeds 33 billion birds annually, representing the largest vaccine-consuming animal segment globally.
• The global cattle population stands at approximately 1.5 billion heads, while swine population approaches 1 billion, supporting sustained demand for porcine and livestock vaccines.
• Aquaculture production surpassed 130 million metric tons annually, driving increased adoption of fish vaccines to reduce antibiotic usage and improve survival rates.
• Companion animal ownership continues to rise, with over 470 million dogs and 370 million cats globally, strengthening demand for preventive pet vaccination programs.

Key Innovators Driving Animal Vaccine Transformation

The key players in the animal vaccine market include Elanco Animal Health Incorporated, Merck & Co., Inc., Phibro Animal Health Corporation, Virbac S.A., Zoetis Inc, among others.

• In July 2025, Zoetis strengthened its global livestock vaccine portfolio by expanding manufacturing capacity and launching enhanced swine and poultry vaccines aimed at improving disease resilience and productivity across commercial farms.
• In May 2025, Boehringer Ingelheim Animal Health advanced its recombinant and vectored vaccine pipeline through expanded production capabilities and strategic collaborations to address emerging animal health threats globally.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Technology
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Elanco Animal Health Incorporated, Merck & Co., Inc., Phibro Animal Health Corporation, Virbac S.A., Zoetis Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Animal Vaccine Market Report Segment

By Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Aquaculture Vaccines
• Companion Animal Vaccines
• Other

By Technology

• Live Attenuated Vaccine
• Killed/Inactive Vaccine
• Recombinant Vaccine
• Vectored Vaccine
• Subunit Vaccine
• DNA Vaccine
• Chimeric Vaccine
• Others

Global Animal Vaccine Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/animal-vaccine-market